Pharmaceutical Technology

MAY 29, 2023

The global pharmaceutical industry experienced a 38% drop in company filings mentions of virtual care in Q1 2023 compared with the previous quarter, with the highest share accounted for by ICON with 25% year-on-year decrease, according to GlobalData’s analysis of over 88 pharmaceutical company filings.

Pharmaceutical Companies 45

Pharmaceutical Companies Pharmaceutical Companies 45

Pharmaceutical Technology

JUNE 7, 2023

Eli Lilly has achieved significant gains in the past quarter, leading to it becoming the most valuable pharmaceutical company in the world, with a market cap of $420bn, surpassing Johnson & Johnson. There have been several Phase III trials for Mounjaro, with SURMOUNT-1 demonstrating a weight loss of up to 22.5%

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceutical Companies Labelling FDA 98

European Pharmaceutical Review

FEBRUARY 3, 2023

Positively, it comes at a time when securing fill finish capacity can be a challenge for many pharmaceutical companies. billion by 2030 The post France gets new sterile liquid drug manufacturing facility appeared first on European Pharmaceutical Review. HPAPI contract manufacturing to value $14.6

Dosage 93

Dosage Compounding Pharmaceutical Companies Pharmaceutical Companies 93

pharmaphorum

JANUARY 24, 2023

In this final instalment of IQVIA EMEA Thought Leadership’s Nine for 2023 three-part series, focusing on issues that will change the direction of healthcare and the pharmaceutical industry this year, three key competitive issues for pharmaceutical companies in 2023 are assessed.

Pharmaceutical Companies 91

Pharmaceutical Companies Pharmaceutical Companies Vaccines 91

Pharmaceutical Technology

AUGUST 26, 2022

This guidance is in line with the WHO’s End TB Strategy, which aims for an 80% fall in worldwide TB incidence and a 90% decrease in TB deaths by 2030, compared with 2015. Sequella is a US-based pharmaceutical company that develops antibiotics to address drug resistant infections.

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceutical Companies Documentation 98

Roots Analysis

MARCH 26, 2024

However, the road for transition from the conventional batch to continuous manufacturing requires a shift in variety of parameters and is still quite unclear to many of the pharmaceutical companies. However, in 2030 as well, North America and Europe are likely to contribute an equal amount of share to the market.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies FDA 52

pharmaphorum

JUNE 8, 2021

At the same time, lots of people with experience at multinational pharmaceutical companies have chosen to return home. All these factors will support the growth of in-house R&D-driven pharmaceutical companies and bring more innovative drugs to Asian markets.”. million in 2030.

Chemotherapy 104

Chemotherapy Pharmaceutical Companies Pharmaceutical Companies Immunization 104

European Pharmaceutical Review

MARCH 7, 2024

Lastly, there is growing prominence and interest in radioligand therapeutics within major pharmaceutical companies, who are increasingly investing in this field, evident through recent acquisitions of Point Biopharma and RayzeBio. What makes targeted alpha therapies a promising new approach against cancer?

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Immunization FDA 52

pharmaphorum

MAY 10, 2022

Jamie Phares, managing director, The Janssen Pharmaceutical Companies of Johnson & Johnson in the Gulf Cooperation Council (GCC), talks about how the healthcare industry needs to come together to reduce its environmental impact and further protect public health. About the author.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Hospitals 52

pharmaphorum

MARCH 10, 2022

“As pipelines shift towards biotechnology, all companies will have to decide between investing in expertise in-house and relying on the pre-existing technological platforms offered by experienced companies.”. The rise of biologics.

Pharmaceutical Companies 92

Pharmaceutical Companies Pharmaceutical Companies Packaging Immunization 92

Roots Analysis

NOVEMBER 27, 2023

Experts have projected that the obesity drug market could reach a valuation of up to USD 100 billion by 2030, further emphasizing the immense potential for companies investing in this therapeutic area.

Pharmaceutical Companies 40

Pharmaceutical Companies Pharmaceutical Companies Labelling 40

pharmaphorum

JUNE 1, 2022

According to the World Health Organization, the world will need more than 40 million new doctors, nurses, frontline healthcare workers, and various other healthcare professionals by 2030. This has not escaped the notice of pharmaceutical companies looking to educate patients on topics, with which they may not have the most health literacy.

Vaccines 142

Vaccines Immunization Hospitals Packaging 142

pharmaphorum

NOVEMBER 28, 2022

Specifically, the company formed a consortium with other pharmaceutical companies to secure power purchase agreements for their suppliers. In October 2021, Pfizer itself sealed a 15-year virtual power purchase agreement with Vesper Energy that would see the latter company deliver 310 megawatts of renewable energy.

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceutical Companies 98

ISPE

SEPTEMBER 29, 2023

Takeda is the first pharmaceutical company worldwide to have implemented this water preservation project, in collaboration with a Belgian start-up Ekopak, on a large scale. By 2026, the site will produce 80% of its electricity consumed on-site and aims to be a net-zero greenhouse gas emissions site by 2030.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Labelling Patient Care 52

pharmaphorum

NOVEMBER 10, 2022

With 90% of adolescents that should be vaccinated by 2030, Luppi deems it an opportunity. We are still in a pandemic, but the World Cancer Series congress itself would not have been possible without pharmaceutical companies investing heavily in research on SARS-CoV-2. Pharma needs to continue to invest in M&D.

Vaccines 81

Vaccines Pharmaceutical Companies Pharmaceutical Companies Labelling 81

European Pharmaceutical Review

SEPTEMBER 21, 2023

billion by 2030. Pharmaceutical companies need to work closely with governments and health authorities to find innovative contracting and payment models, such as outcome-based agreements, which consider the clinical and economic value of the treatment to patients, healthcare systems and society.

Pharmaceutical Companies 76

Pharmaceutical Companies Pharmaceutical Companies FDA 76

pharmaphorum

OCTOBER 17, 2022

. “Novo Nordisk is proud to lead the industry in sustainable business practices, doing our part to give empty pens new purpose,” said the company’s UK general manager, Pinder Sahota. Novo Nordisk is also working towards zero CO2 emissions from operations and transportation by 2030.

Community Pharmacies 62

Community Pharmacies Pharmaceutical Companies Pharmaceutical Companies 62

pharmaphorum

MARCH 31, 2021

Another recent change is the timelier release of scientific information; rather than holding on to clinical trial findings until the ‘perfect’ opportunity to present them at a major congress, 2020 increasingly saw pharmaceutical companies make data public in real time. What are the associated challenges? Conclusion.

Communication 97

Communication Pharmaceutical Companies Pharmaceutical Companies Vaccines 97

European Pharmaceutical Review

DECEMBER 21, 2022

“As the contribution of costs of organic chemicals used as feedstock to the operating expenditures is small, the pharmaceutical companies can spearhead and guide the transition.” So, when could the goal of a net zero pharmaceutical industry be achieved?

Compounding 77

Compounding Pharmaceutical Companies Pharmaceutical Companies Packaging 77

Pharmaceutical Technology

APRIL 28, 2023

At its Biocon Park campus in Bengaluru the company set up and commissioned a new microbial cGMP facility and expanded its mammalian cell manufacturing facility Meanwhile, Bristol Myers Squibb (BMS), one of the world’s largest pharmaceutical companies, celebrated 25 years of collaboration with Syngene in March 2023.

FDA 52

FDA Pharmaceutical Companies Pharmaceutical Companies 52

pharmaphorum

SEPTEMBER 22, 2021

While there has been incredible progress in the HIV response, nearly 38 million people are living with HIV, with more than a million new cases every year, jeopardising the goal to end AIDS as a public health threat by 2030. HIV places enormous burdens on the communities it affects most, straining health systems and government budgets.

Communication 59

Communication Pharmaceutical Companies Pharmaceutical Companies 59

ISPE

MARCH 7, 2023

Transforming Our World: The 2030 Agenda for Sustainable Development.” A collaborative mindset must prevail between pharmaceutical companies, suppliers, and regulators and include strategic partnerships that go beyond the pharmaceutical sector so we can move together to a more sustainable future. 1 United Nations.

Health and Personal Care Stores 52

Health and Personal Care Stores Pharmaceutical Companies Pharmaceutical Companies Communication 52

ISPE

MARCH 6, 2023

[link] A recent study published by My Green Lab 2 presented data from 74 biotechnology and pharmaceutical companies tracking the change in scope 1, 2, and 3 carbon intensity (measured in tons of CO2 emitted vs. the company’s revenue in USD) since 2015. For pharmaceutical companies, purchased goods (e.g.,

Packaging 52

Packaging Pharmaceutical Companies Pharmaceutical Companies Compounding 52

ISPE

MARCH 7, 2023

According to the proposal, all packaging shall be designed for recycling by 1 January 2030 and be recycled at scale by 1 January 2035. A pharmaceutical quality system (PQS) is a management system used to direct and control a pharmaceutical company with regard to quality.

Packaging 52

Packaging Pharmaceutical Companies Pharmaceutical Companies Hospitals 52

Pharmaceutical Technology

JUNE 8, 2023

AstraZeneca has announced its supply chain will be carbon negative by 2030. Of the world’s 20 largest pharmaceutical companies, 17 have launched programmes tailored towards increasing medication access in low- and middle-income countries – up from just eight in 2010. A similar theme is evident in company filings.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Documentation Communication 52

Pharmaceutical Technology

DECEMBER 22, 2022

By 2030, JCAs will be carried out on all medicinal products with an EMA-issued MA. The new joint procedure will launch in Q1 2025 for oncology medicines and other advanced therapy medicinal products and extend to orphan drugs in 2028. Will the joint procedure drive positive change?

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Labelling Communication 52

Pharmaceutical Technology

JANUARY 20, 2023

Pharmaceutical companies need to be prepared to answer the call for increased demand and supply into new markets, ensuring the proper resources and logistics framework are in place. In addition, a paper published in 2019, concluded that the pharmaceutical industry produced 48.55

Pharmaceutical Companies 142

Pharmaceutical Companies Pharmaceutical Companies Packaging Communication 142

Pharmaceutical Technology

DECEMBER 15, 2022

With its highly educated, English-speaking workforce and high-quality medical facilities system, Singapore has attracted leading pharmaceutical companies to open their regional headquarters in the city-state, including Novo Nordisk (Bagsvaerd, Denmark) and GSK.

Vaccines 105

Vaccines Packaging Pharmaceutical Companies Pharmaceutical Companies 105

Pharmaceutical Technology

JUNE 15, 2023

Generic and biosimilar pharmaceutical company and Novartis subsidiary Sandoz announced its plan to accelerate patient access to biosimilars. In a 15 June statement, Sandoz said that it hoped the Act4Biosimilars action plan will provide actionable solutions to overcome barriers preventing patient access to biosimilars.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Communication Patient Care 52